Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0324 Transporter Info | ||||
Gene Name | SLC37A3 | ||||
Transporter Name | Sugar phosphate exchanger 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
Acrolein |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
alpha-pinene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene results in increased methylation of SLC37A3 promoter | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-lapachone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-lapachone results in increased expression of SLC37A3 mRNA | [10] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in decreased expression of SLC37A3 mRNA | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
dicrotophos results in decreased expression of SLC37A3 mRNA | [6] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
di-n-butylphosphoric acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
di-n-butylphosphoric acid affects the expression of SLC37A3 mRNA | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Manganese |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC37A3 mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
manganese chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC37A3 mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methacrylaldehyde |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Naphthoquinones |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Naphthoquinones results in increased expression of SLC37A3 mRNA | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
nickel sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
nickel sulfate results in decreased expression of SLC37A3 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Ozone |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Air Pollutants results in increased abundance of Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone which results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Volatile Organic Compounds co-treated with Ozone results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC37A3 mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
triphenyl phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
triphenyl phosphate affects the expression of SLC37A3 mRNA | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Carcinogen |
|||||
Arsenic |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC37A3 mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Natural Product |
|||||
Resveratrol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Plant Extracts co-treated with Resveratrol results in increased expression of SLC37A3 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Biotoxin |
|||||
T-2 Toxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
T-2 Toxin results in decreased expression of SLC37A3 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Cyclosporine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclosporine increases the expression of SLC37A3 | [1] | |||
Dronabinol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dronabinol inhibits the expression of SLC37A3 | [2] | |||
Doxorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Doxorubicin inhibits the expression of SLC37A3 | [3] | |||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol increases the expression of SLC37A3 | [4] | |||
Tretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tretinoin inhibits the expression of SLC37A3 | [5] | |||
Pesticide/Insecticide |
|||||
Dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dicrotophos inhibits the expression of SLC37A3 | [6] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.